Are we detouring from a direct route to development of HIV vaccines?
Experiments in animal model systems have demonstrated that it is possible for vaccination to elicit immune responses that can prevent or significantly delay lentiviral infection and perhaps disease. To facilitate the development of effective HIV vaccines, current research and development efforts must utilize the appropriate HIV strains. International scientific communities and vaccine manufacturers, with the support of governments, should now unite to ensure that the most direct route possible will be taken.
Fultz
P N
PN
Department of Microbiology, University of Alabama, Birmingham 35294.
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002986:Clinical Trials as Topic / Q000379:methods; D006678:HIV / Q000145:classification / Q000276:immunology*; D015483:HIV Antibodies / Q000096:biosynthesis / Q000276:immunology; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology; D007114:Immunization; D008251:Macaca / Q000276:immunology; D002679:Pan troglodytes / Q000276:immunology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D014765:Viral Vaccines
D000914:Antibodies, Viral; D015483:HIV Antibodies; D014765:Viral Vaccines